Detalhe da pesquisa
1.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Oncologist
; 28(1): 23-32, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239405
2.
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.
Metabolomics
; 19(7): 60, 2023 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344702
3.
Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomics.
Proteomics
; 22(3): e2100110, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624180
4.
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.
BMC Cancer
; 20(1): 307, 2020 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293335
5.
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients.
Future Oncol
; 15(30): 3483-3490, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580166
6.
Orbital and conjunctival metastasis from lobular breast carcinoma.
Orbit
; 36(4): 197-200, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441073
7.
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.
Oncologist
; 20(2): 111-2, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601966
8.
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
Hum Mol Genet
; 20(16): 3289-303, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21596841
9.
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.
Clin Transl Oncol
; 25(12): 3519-3526, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329429
10.
Targeting the endothelin axis in prostate carcinoma.
Tumour Biol
; 33(2): 421-6, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203496
11.
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer.
Biomed Pharmacother
; 149: 112844, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339109
12.
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
PLoS Genet
; 4(4): e1000054, 2008 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18437204
13.
Cancer survivors referred to a long-term survivorship outpatient service within academic medical oncology: descriptive study.
J Cancer Surviv
; 15(6): 811-817, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230726
14.
POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients.
Pharmaceutics
; 13(11)2021 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34834357
15.
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 7(12): 1791-1799, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617955
16.
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.
BMC Cancer
; 10: 336, 2010 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20584321
17.
Angiogenesis as a therapeutic target in urothelial carcinoma.
Anticancer Drugs
; 21(10): 890-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20729712
18.
Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy.
Nephrol Dial Transplant
; 25(3): 1001-3, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20019017
19.
Palliative care is a key component of daily practice in oncology: descriptive study of hospitalisation events at an oncology treatment centre.
Support Care Cancer
; 18(9): 1231-4, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20508952
20.
Bayesian networks established functional differences between breast cancer subtypes.
PLoS One
; 15(6): e0234752, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525929